news

CALIXAR to present at World Vaccine Congress in Washington

Anass JAWHARI, CSO of CALIXAR will be giving 3 presentations on new exciting results:

 

  • Presentation 1: Bioprocessing and Manufacturing stream entitled New compounds to improve the quality/stability of viral antigens in vaccine formulation”, on April 11th at 10:10 AM.
  • Presentation 2: Influenza and Respiratory Vaccines stream entitled “New fragmentation and solubilization / stabilization approaches: case study on the influenza”, on April 11th at 12:40 AM.
  • Presentation 3: Veterinary Vaccines stream entitled “New fragmentation and solubilization approaches toward bacterial and viral vaccines”, on April 12th at 09:40 AM.

 

You are welcome to attend these talks. Further data that are not communicated here can also be discussed after the presentation and during the poster sessions.

 

About the World Vaccine Congress 2017

 

The 17th Annual World Vaccine Congress is the place where the global vaccine industry meets to discuss commercial and scientific issues around regulation, strategy, manufacturing, trials, partnering, influenza, cancer, emerging diseases and veterinary vaccines.

 

world-vaccine-congress-washington-2017

Contact: lmesnard@calixar.com

 ————————————————

DATES : April 10-12, 2017

MORE INFO : World Vaccine Congress 2017